Pfizer Collaborates with Akzo Nobel over New Antipsychotic

By Business Review Editor

Pharma Deals Review: Vol 2003 Issue 42 (Table of Contents)

Published: 3 Dec-2003

DOI: 10.3833/pdr.v2003.i42.843     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

Pharmaceutical giant Pfizer entered into a collaboration agreement with Organon to develop asenapine for treating schizophrenia and bipolar disorder...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details